Skysona (risankizumab) is a prescription medicine used to treat moderate to severe plaque psoriasis in adults. It works by targeting a specific protein in the body that is involved in the inflammation that causes psoriasis.
How Skysona Works:
- Targets IL-23: Skysona specifically targets a protein called interleukin-23 (IL-23), which plays a key role in triggering the inflammation that causes psoriasis.
- Reduces Inflammation: By blocking IL-23, Skysona helps to reduce the inflammation in the skin, leading to clearer skin and improved symptoms.
Benefits of Using Skysona:
- Clearer Skin: Skysona can help to significantly reduce the redness, scaling, and itching associated with plaque psoriasis.
- Improved Quality of Life: By improving skin symptoms, Skysona can lead to a better quality of life for individuals with psoriasis.
- Long-Term Relief: Skysona is administered by injection every 12 weeks, providing long-term relief from psoriasis symptoms.
Important Considerations:
- Prescription Medication: Skysona is a prescription medication and should only be used under the guidance of a healthcare professional.
- Potential Side Effects: Like all medications, Skysona can have side effects. Some common side effects include upper respiratory tract infection, headache, and injection site reactions.
Conclusion:
Skysona is a valuable treatment option for individuals with moderate to severe plaque psoriasis, offering targeted relief from symptoms and improved quality of life.
